Source: Annual Congress 2009 - Translational research/biomarkers
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. Miralpeix, A. Gavalda, E. Calama, M. Gomez-Angelats, C. Carcasona, J. Llenas, J. Beleta (Barcelona, Spain). Functional studies of aclidinium bromide at guinea pig M₂ and M₃ receptors in vitro. Eur Respir J 2009; 34: Suppl. 53, 2938

Member's Comments

No comment yet.

Related content which might interest you: Inhibitory effect of Crocus sativus (saffron) on histamine (H1) receptors of guinea pig tracheal chains Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Assessment of the potency and duration of action of aclidinium bromide in guinea pig isolated trachea in vitro Source: Annual Congress 2007 - Recent advances in our understanding of the mechanisms of asthma treatment Year: 2007 Muscarinic receptor selectivity of aclidinium bromide and glycopyrrolate in vitro Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 The in-vitro pharmacology of PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 PF-3429281 – A novel inhaled dual antimuscarinic/β2 adrenoceptor agonist in the anaesthetised dog model of bronchoconstriction Source: Annual Congress 2010 - Bronchodilators in airways disease Year: 2010 The in-vitro pharmacology of PF-4522971 – A novel inhaled Muscarinic M3 Antagonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 The in vitro biology of PF-00610355 – a novel β2 adrenoceptor agonist with a long duration of action Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Drug product stability of aclidinium bromide in Genuair® Source: Annual Congress 2012 - The best of pharmacology treatments of airway diseases: new devices and drugs Year: 2012 Comparison between SCOT-15® and Perfadex® as lung preservation solutions Source: Annual Congress 2011 - Immunobiology in the transplanted lung: experimental and clinical evaluations Year: 2011 PF-00610355 – an inhaled β2 adrenoceptor agonist with superior potency and duration of action (DoA) to salmeterol in the conscious dog model of bronchoconstriction Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009 Demonstration of dual pharmacology in vivo of PF-3429281: A novel inhaled dual antimuscarinic/β2 agonist Source: Annual Congress 2010 - Regulation of airway hyperresponsiveness and bronchodilators Year: 2010 Relaxant effect of crocus sativus (saffron) on guinea pig tracheal chains and its possible mechanism(s) Source: Annual Congress 2011 - Airway smooth muscle cells and fibroblasts: cell biology Year: 2011 Effects of roflumilast and other PDE4 inhibitors on [3H] thymidine incorporation in human bronchial smooth muscle cells Source: Eur Respir J 2005; 26: Suppl. 49, 717s Year: 2005 Endogenous PGE2 contributes to antigen-induced contractions of guinea pig trachea Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Optimization of inhalation treatment – Evaluation of influence of PNEUMOlogic® and Optimiser® spacers on aerosol particle distribution from pMDI-EB Source: Annual Congress 2011 - Drug delivery and pharmacokinetics I Year: 2011 Efficacy of UR-63325, a new H4 receptor antagonist, in two rodent asthma models Source: Annual Congress 2010 - Models of airways disease Year: 2010 A novel dual-agonist challenge model in guinea pigs for assessment of individual and combined muscarinics antagonists and b2 adrenoceptor agonists bronchodilator efficacy Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011 Effects of intratracheal pf-00610355, an inhaled β2 adrenoceptor agonist, in anaesthetised animals Source: Annual Congress 2009 - New bronchodilators Year: 2009 Alterations in ORMDL expression in experimental esthma Source: Annual Congress 2012 - Mechanisms and risk of childhood asthma and allergy Year: 2012 Sensitivity and specificity of airway hyperreactivity (AHR) based on methacholine challenge (MCH) tests – Comparison of sGeff with FEV1 and MEF50 as target parameter Source: Annual Congress 2012 - Bronchial challenge as a biomarker of respiratory disease Year: 2012